Medicine and Dentistry
Patient
83%
Hepatitis C
67%
Prevalence
60%
Hepatitis C Virus
50%
Diagnosis
32%
Combination Therapy
26%
Screening
26%
Motivation
24%
Infection
23%
Chronic Liver Disease
22%
Laboratory Test
20%
Liver Biopsy
20%
Assessment
20%
Liver Function
20%
Prophylaxis
20%
Hepatitis B
20%
Childbirth
18%
Hepatitis Virus
15%
Exercise
14%
Serum
13%
Immunogenetics
13%
Child
11%
Complication
8%
Fibrosis
8%
Hepatitis B Virus
8%
Age
7%
Viral Clearance
6%
Morbidity
6%
Prognosis
6%
Liver Toxicity
6%
Liver Disease
6%
Non Invasive Procedure
6%
Antigen
6%
Disease Course
6%
Programmed Cell Death
6%
Harm Reduction
6%
Restylane
6%
Keratin 18
6%
Accuracy
6%
Disease Marker
6%
Chemotherapeutic Agent
6%
Drug
6%
Absence
5%
Population
5%
COVID-19
5%
Hepatitis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C
93%
Hepatitis C Virus
80%
Prevalence
65%
Diseases
49%
Infection
38%
Elimination
34%
Mortality
28%
Morbidity
24%
Liver Cirrhosis
22%
Antivirus Agent
22%
Hepatitis B
22%
Ritonavir
20%
Dasabuvir
20%
Ombitasvir
20%
Pathogen Clearance
20%
Paritaprevir
20%
Hepatitis C Virus Genotype 1
20%
Ribavirin
20%
Hemophilia
20%
Leukocyte Antigen
13%
Chronic Hepatitis C
9%
Antiviral Therapy
9%
Hepatitis B Virus
8%
Adverse Event
8%
Deterioration
5%
Drug
5%
Absence
5%
Nursing and Health Professions
Hepatitis C
100%
Prevalence
100%
Infection
30%
Diagnosis
30%
World Health Organization
25%
Disease Burden
22%
Epidemiology
20%
Hepatitis B
20%
Prophylaxis
20%
Consensus
15%
Time
14%
Drug Use
12%
Epidemiological Data
12%
Viremia
11%
Uncertainty
10%
Injection
10%
Gender
10%
Infection Control
10%
Chronic Hepatitis C
10%
Analysis
8%
Mortality
7%
Antiviral Therapy
7%
Virus Load
6%
Prevention
6%
Screening
5%
Viral Clearance
5%
Combination Therapy
5%
